Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 17.50
+0.60 (3.55%)
Oct 15, 2026, 1:40 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 404.6 million as of October 14, 2026. It is the 25,328th most valuable company in the world and the 150th biggest in Poland. Its market cap has decreased by 32.04% in one year.
Market Cap
404.60M
Enterprise Value
421.95M
Revenue
83.94M
Global Rank
Country Rank
#150 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 404.60M, an increase of 616.07%. That is a compound annual growth rate of 13.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 404.60M | -35.42% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 552.55M |
| Bioceltix | 385.04M |
| Captor Therapeutics Spolka Akcyjna | 381.20M |
| BIOTON | 326.28M |
| Synthaverse | 213.67M |
| Molecure | 134.54M |
| Mabion | 127.68M |
| Poltreg | 121.29M |